TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33541227

Group type: EXPERIMENTAL
Intervention: National Death Index (NDI) for HIV deaths
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: National Death Index (NDI) for non–AIDS‐related infectious diseases
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: National Death Index (NDI) for non–AIDS‐related cancers
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: National Death Index (NDI) for substance abuse
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: National Death Index (NDI) for heart disease
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: National Death Index (NDI) for hepatitis B/C
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: National Death Index (NDI) for mental illness
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Agreement between expert review and NDI for HIV deaths
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Agreement between expert review and NDI for heart disease
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Agreement between expert review and NDI for hepatitis B/C
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Agreement between expert review and NDI for non–AIDS‐related infectious diseases
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Agreement between expert review and NDI for non–AIDS‐related cancers
Number of subjects: 50
Study: 33248530

Group type: EXPERIMENTAL
Intervention: IPR enhanced with youth- and parent-directed online Single-Session Interventions (SSIs) designed to reduce youths’ internalizing symptoms and improve parents’ mental health treatment expectancies.
Number of subjects: 246

Group type: COMPARATOR
Intervention: Information, Psychoeducation, and Referral (IPR; ie, usual care)
Number of subjects: 246
Study: 35334836

Group type: EXPERIMENTAL
Intervention: Three eggs per day for 4 weeks (choline equivalent of 400 mg/day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Choline bitartrate (CB) supplement for 4 weeks (choline equivalent of 400 mg/day)
Number of subjects: 23
Study: 32319963

Group type: EXPERIMENTAL
Intervention: Smartphone-based self-monitoring (Lose it!)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Food journal self-monitoring (paper diaries)
Number of subjects: 36
Study: 32346709

Group type: EXPERIMENTAL
Intervention: High-speed turbine minimally invasive surgery combined with immediate implantation
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional surgery combined with immediate implantation
Number of subjects: 80
Study: 33687312

Group type: EXPERIMENTAL
Intervention: Nursing care program based on the Theory of Human Caring (THC) alongside routine nursing care for five sessions
Number of subjects: 52

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 52
Study: 32936010

Group type: EXPERIMENTAL
Intervention: Letrozole (2.5 mg/day) combined with oral contraceptives (Desogestrel and Ethinylestradiol Tablets)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Oral contraceptives (Desogestrel and Ethinylestradiol Tablets) alone
Number of subjects: 820
Study: 34705283

Group type: EXPERIMENTAL
Intervention: Isatuximab (Isa) 10 mg/kg weekly for 4 weeks then every 2 weeks (QW-Q2W) in combination with pomalidomide/dexamethasone (Pd)
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Switching to a monthly dosing regimen of Isatuximab after 6 months
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Isatuximab (Isa) 10 mg/kg QW-Q2W regimen
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Patients with good prognostic characteristics and stable, very good partial response
Number of subjects: 256
Study: 32673309

Group type: EXPERIMENTAL
Intervention: Higher between-day variability in sleep onset
Number of subjects: 967

Group type: EXPERIMENTAL
Intervention: Sleep onset between 19:00 and 22:00
Number of subjects: 967

Group type: EXPERIMENTAL
Intervention: Higher between-day variability in sleep duration
Number of subjects: 967
Study: 35866676

Group type: EXPERIMENTAL
Intervention: Mouthwash with Sambucus williamsii var. coreana extract (1x/day for 30 s for 1 day or 5 days)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Saline gargle (1x/day for 30 s)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Mouthwash with Sambucus williamsii var. coreana extract (5 days treatment)
Number of subjects: 77
Study: 33646464

Group type: EXPERIMENTAL
Intervention: Trastuzumab deruxtecan (T-DXd)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy of physician’s choice
Number of subjects: 0
Study: 32516810

Group type: EXPERIMENTAL
Intervention: Pantoprazole
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 33215715

Group type: EXPERIMENTAL
Intervention: Higher quality caregiving in adolescence
Number of subjects: 0
Study: 33389399

Group type: EXPERIMENTAL
Intervention: CTC-oriented personalized adjuvant therapy (experimental group, n = 68)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 128
Study: 36334308

Group type: EXPERIMENTAL
Intervention: Low-dose cognitively engaging movement games (20-min)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: High-dose cognitively engaging movement games (40-min)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 34330261

Group type: EXPERIMENTAL
Intervention: kNN models using learned patient similarity
Number of subjects: 30

Group type: COMPARATOR
Intervention: kNN models using Euclidean distance
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: kNN models using learned patient similarity to identify top k nearest neighbors
Number of subjects: 30

Group type: COMPARATOR
Intervention: Reference models
Number of subjects: 30
Study: 36630863

Group type: COMPARATOR
Intervention: High-frequency DBS (130 Hz)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Mid-frequency DBS (60 Hz)
Number of subjects: 14

Group type: COMPARATOR
Intervention: DBS off
Number of subjects: 14

Group type: COMPARATOR
Intervention: Both 60 Hz and 130 Hz DBS
Number of subjects: 14
Study: 34251664

Group type: EXPERIMENTAL
Intervention: iView Video Laryngoscope (VL)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 32
Study: 35613527

Group type: EXPERIMENTAL
Intervention: Aggressive behavior toward an automated vehicle (AV)
Number of subjects: 956

Group type: COMPARATOR
Intervention: Aggressive behavior toward a human driver
Number of subjects: 956

Group type: EXPERIMENTAL
Intervention: Victim identity salience (high)
Number of subjects: 956

Group type: EXPERIMENTAL
Intervention: Victim identity salience (low)
Number of subjects: 956
Study: 33669400

Group type: EXPERIMENTAL
Intervention: Diet plan with potentially beneficial foods for intestinal permeability (IP) in IBD patients (n = 14)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Diet plan with potentially beneficial foods for intestinal permeability (IP) in control participants without disease (n = 14)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No intervention in IBD patients (n = 11)
Number of subjects: 53

Group type: COMPARATOR
Intervention: No intervention in control participants without disease (n = 14)
Number of subjects: 53
Study: 32134035

Group type: EXPERIMENTAL
Intervention: 37% phosphoric acid etching
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Er, Cr: YSGG laser irradiation at 3W
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no surface treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1W Er, Cr: YSGG laser irradiation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2W Er, Cr: YSGG laser irradiation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 9.6% hydrofluoric acid etching
Number of subjects: 60
Study: 33840312

Group type: EXPERIMENTAL
Intervention: Counseling for a Healthy Diet
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet Counseling
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Highest observed MCAP Score
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: MCAP Score correlation
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Improvements in MCAP Score
Number of subjects: 120
Study: 33373276

Group type: EXPERIMENTAL
Intervention: FLAMSA‐Bu
Number of subjects: 244

Group type: COMPARATOR
Intervention: Control (fludarabine‐based RIC regimen)
Number of subjects: 244
Study: 35623869

Group type: EXPERIMENTAL
Intervention: l-Carnitine (3000 mg/day) for 7 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 54
Study: 33258531

Group type: EXPERIMENTAL
Intervention: One-stage spinal cord stimulation (SCS) procedure (no screening trial)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Two-stage spinal cord stimulation (SCS) procedure (with screening trial)
Number of subjects: 31
Study: 33822328

Group type: EXPERIMENTAL
Intervention: Cabozantinib
Number of subjects: 397

Group type: COMPARATOR
Intervention: Ramucirumab
Number of subjects: 397
Study: 33594771

Group type: EXPERIMENTAL
Intervention: Concomitant durvalumab during chemo/radiation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: No additional therapy during chemo/radiation therapy
Number of subjects: 0
Study: 32724912

Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0
Study: 33850272

Group type: EXPERIMENTAL
Intervention: Sustained-release isosorbide mononitrate (40–60 mg)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 34787298

Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (IHT) performed three times per week (4 x 2 minutes at 30% of maximal voluntary contraction, one-minute rest between bouts, alternating the hands)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Isometric handgrip training (IHT)
Number of subjects: 63
Study: 32233338

Group type: EXPERIMENTAL
Intervention: Liraglutide (3.0 mg) plus lifestyle therapy
Number of subjects: 251

Group type: COMPARATOR
Intervention: Placebo plus lifestyle therapy
Number of subjects: 251
Study: 34505234

Group type: EXPERIMENTAL
Intervention: Feedback messages indicating membership in an elite group of 'Top Performers' or actionable recommendations for 'Not Top Performers'
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 214
Study: 34879493

Group type: EXPERIMENTAL
Intervention: Lidocaine spray (10%)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 67
Study: 36059410

Group type: EXPERIMENTAL
Intervention: Collaborative multidisciplinary team nursing care based on the WeChat platform (experimental group)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional nursing measures and health education (control group)
Number of subjects: 56
Study: 34117621

Group type: EXPERIMENTAL
Intervention: Achieved LDL-C targets
Number of subjects: 1521

Group type: COMPARATOR
Intervention: Not achieving LDL-C targets
Number of subjects: 1521
Study: 32770972

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (loading dose of 20,000 or 40,000 IU daily for the first 11 days, followed by a maintenance dose of 2000 IU daily)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456
Study: 33752070

Group type: EXPERIMENTAL
Intervention: 40 mg/kg ASTA
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: 40 and 80 mg/kg ASTA
Number of subjects: 450

Group type: COMPARATOR
Intervention: 0 mg/kg ASTA (Control)
Number of subjects: 450
Study: 32836109

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1152

Group type: COMPARATOR
Intervention: Medical care as usual (CAU)
Number of subjects: 1152

Group type: EXPERIMENTAL
Intervention: Treatment (Escitalopram)
Number of subjects: 1152
Study: 35361992

Group type: EXPERIMENTAL
Intervention: Inoculation with 10 TCID50 of wild-type SARS-CoV-2 virus
Number of subjects: 36
Study: 34324910

Group type: EXPERIMENTAL
Intervention: Genetic explanation
Number of subjects: 545

Group type: COMPARATOR
Intervention: Environmental explanation
Number of subjects: 545

Group type: COMPARATOR
Intervention: No label/description
Number of subjects: 545

Group type: COMPARATOR
Intervention: Polycystic ovary syndrome label
Number of subjects: 545

Group type: COMPARATOR
Intervention: Weight label
Number of subjects: 545
Study: 33028261

Group type: EXPERIMENTAL
Intervention: e-health web-based platform offering a personalized lifestyle program
Number of subjects: 860

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 860
Study: 35091847

Group type: EXPERIMENTAL
Intervention: VR group (lecture using VR images)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3D group (lecture using 3D images)
Number of subjects: 60
Study: 32589512

Group type: EXPERIMENTAL
Intervention: Research priority areas identified by the Delphi process
Number of subjects: 66
Study: 32739671

Group type: EXPERIMENTAL
Intervention: Structured limbs-exercise program (24 weeks, 3 supervised sessions/week for the first 12 weeks, 3 unsupervised sessions/week for the following 12 weeks)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Structured limbs-exercise program
Number of subjects: 116

Group type: COMPARATOR
Intervention: Health promotion classes alone
Number of subjects: 116
Study: 35521002

Group type: EXPERIMENTAL
Intervention: Pharmaceutical service intervention
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 190
Study: 34987595

Group type: EXPERIMENTAL
Intervention: Continuous Acupuncture Treatment (CAT) group - 5 times/week for 4 weeks
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Intermittent Acupuncture Treatment (IAT) group - 3 times/week for 4 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group - no acupuncture, received routine rehabilitation training
Number of subjects: 72
Study: 32303198

Group type: EXPERIMENTAL
Intervention: ACP-counselling offered by trained nurses
Number of subjects: 960

Group type: COMPARATOR
Intervention: Optimised usual care
Number of subjects: 960
Study: 35565886

Group type: EXPERIMENTAL
Intervention: Shelf tag intervention in seven Australian supermarkets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shelf tag intervention
Number of subjects: 0
Study: 33162599

Group type: EXPERIMENTAL
Intervention: Etomidate infusion at a rate of 0.07 mg kg‐1 min‐1
Number of subjects: 70

Group type: COMPARATOR
Intervention: Propofol infusion of 0.7 mg kg‐1 min‐1
Number of subjects: 70
Study: 35353329

Group type: EXPERIMENTAL
Intervention: Invasive revascularization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimal medical therapy
Number of subjects: 0
Study: 33620158

Group type: EXPERIMENTAL
Intervention: 5% P. purpureum
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 10% P. purpureum
Number of subjects: 300

Group type: COMPARATOR
Intervention: Basic commercial diet
Number of subjects: 300
Study: 35702925

Group type: EXPERIMENTAL
Intervention: Child-Centred Health Dialogue intervention
Number of subjects: 1197

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 1197
Study: 33743292

Group type: EXPERIMENTAL
Intervention: 1.8 g protein/kg body weight (BW)/d
Number of subjects: 42

Group type: COMPARATOR
Intervention: 1.2 g protein/kg BW/d (standard group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standard group
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 42
Study: 34999806

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve implantation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgical aortic valve replacement
Number of subjects: 0
Study: 33616345

Group type: EXPERIMENTAL
Intervention: GDM group
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study: 34838305

Group type: EXPERIMENTAL
Intervention: NaCl (twice/day application for 5 days by caregiver)
Number of subjects: 64

Group type: COMPARATOR
Intervention: CuSO4 (single application by clinician)
Number of subjects: 64
Study: 32872064

Group type: EXPERIMENTAL
Intervention: Nurse-led program (standard care plus telehealth intervention including inquiring about medical condition, providing feedback, counseling, and emotional support)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 0
Study: 34031451

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (assumed increase of 20 nmol/L in 25OHD)
Number of subjects: 1000
Study: 32101256

Group type: EXPERIMENTAL
Intervention: Lebrikizumab 125 mg every 4 weeks
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Lebrikizumab 250 mg every 4 weeks
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Lebrikizumab 250 mg every 2 weeks
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Lebrikizumab (high-dose)
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: Lebrikizumab
Number of subjects: 280
Study: 36473395

Group type: EXPERIMENTAL
Intervention: Endovascular thrombectomy (EVT)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Follow-up infarct volume (FIV)
Number of subjects: 500
Study: 34077457

Group type: EXPERIMENTAL
Intervention: Click-based echolocation training over 20 sessions in 10 weeks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up survey for blind participants
Number of subjects: 0
Study: 32975061

Group type: EXPERIMENTAL
Intervention: ABT13107
Number of subjects: 192

Group type: COMPARATOR
Intervention: Hyalobarrier®
Number of subjects: 192
Study: 35188581

Group type: EXPERIMENTAL
Intervention: Brolucizumab 6 mg loading (three monthly loading doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brolucizumab 6 mg non-loading (one initial injection)
Number of subjects: 0
Study: 33668789

Group type: EXPERIMENTAL
Intervention: Smartwatch-assisted CPR
Number of subjects: 36

Group type: COMPARATOR
Intervention: Non-smartwatch-assisted CPR
Number of subjects: 36
Study: 32861442

Group type: COMPARATOR
Intervention: Global (GB) medium
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: G-TL medium
Number of subjects: 820
Study: 35108217

Group type: EXPERIMENTAL
Intervention: Amniotic membrane dressing
Number of subjects: 70

Group type: COMPARATOR
Intervention: Nitrofurazone-impregnated dressing
Number of subjects: 70
Study: 32147955

Group type: EXPERIMENTAL
Intervention: Sildenafil (PDE5 inhibitor)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35227250

Group type: EXPERIMENTAL
Intervention: Cell-free and concentrated ascites reinfusion therapy (CART)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Simple paracentesis (Control)
Number of subjects: 20
Study: 32384527

Group type: EXPERIMENTAL
Intervention: Standardized wound care order set
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (pre-change)
Number of subjects: 21
Study: 34664874

Group type: EXPERIMENTAL
Intervention: 4-week nurse-led stroke self-management programme (SSMP)
Number of subjects: 64
Study: 34464996

Group type: EXPERIMENTAL
Intervention: Probiotic VSL#3
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33444120

Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise intervention (aerobic/resistance 3×/wk, starting at ∼13th gestation week until birth)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonexercise control group
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups (exercise and control)
Number of subjects: 80
Study: 35123557

Group type: EXPERIMENTAL
Intervention: Lycra® sleeve
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo sleeve
Number of subjects: 100
Study: 33491383

Group type: EXPERIMENTAL
Intervention: 1‐day‐old biofilm
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 3‐day‐old biofilm
Number of subjects: 23

Group type: COMPARATOR
Intervention: no biofilm (control)
Number of subjects: 23
Study: 35706479

Group type: EXPERIMENTAL
Intervention: modified constraint‐induced movement therapy (mCIMT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: standard care (Control)
Number of subjects: 31
Study: 33975590

Group type: EXPERIMENTAL
Intervention: Patient-friendly discharge letter (PFDL)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Conventional discharge letter (CDL)
Number of subjects: 74
Study: 35183134

Group type: EXPERIMENTAL
Intervention: Food literacy and physical activity intervention consisting of five interactive group sessions, 150 min each, including infographics, vegetable recipes, and personalized goals.
Number of subjects: 0
Study: 35373003

Group type: EXPERIMENTAL
Intervention: TAKE (taking BP medications as prescribed)
Number of subjects: 131

Group type: COMPARATOR
Intervention: HOLD (holding BP medications dosed more than once daily)
Number of subjects: 131
Study: 32393654

Group type: EXPERIMENTAL
Intervention: Intensive atorvastatin (IA) with bone marrow mononuclear cells (MNCs)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Regular atorvastatin (RA) with bone marrow mononuclear cells (MNCs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intensive atorvastatin (IA) with placebo
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo with bone marrow mononuclear cells (MNCs)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32075667

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied while participants paid attention to the FDI muscle
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied while participants paid attention to the sound
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Anodal tDCS applied without attention to FDI muscle or sound
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combination of tDCS and attention to the APB muscle
Number of subjects: 33
Study: 35134768

Group type: EXPERIMENTAL
Intervention: Passive suspension system 'Levitas' (Technomex, Poland)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard rehabilitation measures (control group)
Number of subjects: 85
Study: 32711530

Group type: EXPERIMENTAL
Intervention: Knowledge, attitudes, and practices survey regarding cervical cancer and HPV screening
Number of subjects: 679

Group type: COMPARATOR
Intervention: Knowledge of cervical cancer and HPV screening
Number of subjects: 679
Study: 33571532

Group type: EXPERIMENTAL
Intervention: Giant vacuoles (GVs) with I‐pores in high-flow areas
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Giant vacuoles (GVs) with I‐pores
Number of subjects: 2